CSIMarket
 


Odonate Therapeutics Inc   (ODT)
Other Ticker:  
 
 

ODT's EPS Net Growth by Quarter and Year

Odonate Therapeutics Inc 's EPS Net results by quarter and year




ODT EPS Net (in $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - -0.86 -0.66 -0.72
III Quarter September -0.37 -0.93 -0.88 -0.98
II Quarter June -0.58 -1.09 -0.01 -0.01
I Quarter March -0.90 -0.99 -1.16 -0.69
FY   -1.85 -3.87 -2.71 -2.40



ODT EPS Net third quarter 2021 Y/Y Growth Comment
Odonate Therapeutics Inc in the third quarter 2021 recorded EPS net loss of $ -0.37 .

According to the results reported in the third quarter 2021, Odonate Therapeutics Inc achieved the best EPS Net growth in Major Pharmaceutical Preparations industry. While Odonate Therapeutics Inc ' s EPS Net no change of % ranks overall at the positon no. in the third quarter 2021.




ODT EPS Net ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Odonate Therapeutics Inc 's third quarter 2021 EPS Net $ -0.37 ODT's Income Statement
Odonate Therapeutics Inc 's third quarter 2020 EPS Net $ -0.93 Quarterly ODT's Income Statement
New: More ODT's historic EPS Net Growth >>


ODT EPS Net (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Odonate Therapeutics Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ODT's III. Quarter Q/Q EPS Net Comment
Even if Odonate Therapeutics Inc in the III. Quarter 2021 admitted EPS net loss of $ -0.37 , some analyst mentioned, that this point to recovery compare to the -0.58 in the second quarter.

Within Major Pharmaceutical Preparations industry Odonate Therapeutics Inc achieved highest sequential EPS Net growth. While Odonate Therapeutics Inc 's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ODT's III. Quarter Q/Q EPS Net Comment
Despite the fact, that Odonate Therapeutics Inc in the III. Quarter 2021 showed EPS net loss of $ -0.37 , management said, that those numbers point to recovery in contrast to the -0.58 in the second quarter.

Within Major Pharmaceutical Preparations industry Odonate Therapeutics Inc achieved highest sequential EPS Net growth. While Odonate Therapeutics Inc 's EPS Net growth quarter on quarter, overall rank is .


Odonate Therapeutics Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
Cumulative EPS Net 12 Months Ending $ -2.71 $ -3.27 $ -3.78 $ -3.87 $ -3.67
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment


Odonate Therapeutics Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment


Odonate Therapeutics Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
ODT's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for ODT's Competitors
EPS Net Growth for Odonate Therapeutics Inc 's Suppliers
EPS Net Growth for ODT's Customers

You may also want to know
ODT's Annual Growth Rates ODT's Profitability Ratios ODT's Asset Turnover Ratio ODT's Dividend Growth
ODT's Roe ODT's Valuation Ratios ODT's Financial Strength Ratios ODT's Dividend Payout Ratio
ODT's Roa ODT's Inventory Turnover Ratio ODT's Growth Rates ODT's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Sep 30 2021 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Sep 30 2021
Charles River Laboratories International inc -0.99%$ -0.985 
Biomx Inc -2.63%$ -2.632 
Dexcom Inc -2.74%$ -2.740 
Quest Diagnostics Inc-2.90%$ -2.899 
Amgen Inc -3.50%$ -3.499 
Quidelortho Corp-4.69%$ -4.690 
Universal Health Services Inc -7.80%$ -7.801 
Eli Lilly And Company-8.27%$ -8.271 
Abiomed Inc -8.82%$ -8.824 
United Therapeutics Corporation-10.94%$ -10.938 
Community Health Systems Inc -12.37%$ -12.371 
Pro dex Inc -12.50%$ -12.500 
Laboratory Corporation Of America Holdings-15.62%$ -15.621 
Bristol myers Squibb Company-15.85%$ -15.854 
Semler Scientific Inc -16.39%$ -16.393 
Electromed Inc -16.67%$ -16.667 
Lemaitre Vascular Inc -18.92%$ -18.919 
Biodelivery Sciences International Inc -22.22%$ -22.222 
Owens and Minor inc-23.68%$ -23.684 
Co diagnostics Inc -28.30%$ -28.302 
Nature s Sunshine Products inc -29.41%$ -29.412 
Stryker Corp-30.06%$ -30.061 
Collegium Pharmaceutical Inc -31.25%$ -31.250 
Hologic Inc-32.23%$ -32.233 
Msa Safety Incorporated-32.39%$ -32.394 
Integrated Biopharma Inc-33.33%$ -33.333 
Amedisys Inc -36.57%$ -36.574 
Zimmer Biomet Holdings Inc -40.52%$ -40.517 
Retractable Technologies inc -42.42%$ -42.424 
Viemed Healthcare Inc -42.86%$ -42.857 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com